标题
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
作者
关键词
-
出版物
LEUKEMIA
Volume 28, Issue 3, Pages 680-689
出版商
Springer Nature
发表日期
2013-08-05
DOI
10.1038/leu.2013.231
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies
- (2013) D J DeAngelo et al. LEUKEMIA
- Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
- (2013) D Cirstea et al. LEUKEMIA
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Bortezomib for AL amyloidosis: moving forward
- (2011) M. A. Dimopoulos et al. BLOOD
- Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide
- (2011) L. Santo et al. CLINICAL CANCER RESEARCH
- Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy
- (2011) M Gupta et al. LEUKEMIA
- PLDing a case for angiogenesis
- (2010) A. Hamik et al. BLOOD
- A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells
- (2010) T. Hideshima et al. BLOOD
- Nonhistone protein acetylation as cancer therapy targets
- (2010) Brahma N Singh et al. Expert Review of Anticancer Therapy
- Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
- (2010) A Quintás-Cardama et al. LEUKEMIA
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
- (2009) Sumihito Togi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
- (2009) Jia-Lin Lee et al. JOURNAL OF CELL BIOLOGY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis
- (2009) Q-L Zhang et al. LEUKEMIA
- Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death
- (2009) C. Li et al. MOLECULAR CANCER THERAPEUTICS
- Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo
- (2009) R. Burger et al. MOLECULAR CANCER THERAPEUTICS
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started